Singh P, Le N, Karniychuk U
J Med Virol. 2025; 97(2):e70205.
PMID: 39895481
PMC: 11788880.
DOI: 10.1002/jmv.70205.
Le N, Singh P, Sabir A, Trus I, Karniychuk U
Virol J. 2024; 21(1):285.
PMID: 39522048
PMC: 11549788.
DOI: 10.1186/s12985-024-02557-x.
Lee H, Park S, Lim J
Int J Mol Sci. 2024; 25(20).
PMID: 39456919
PMC: 11508327.
DOI: 10.3390/ijms252011138.
Sabir A, Le N, Singh P, Karniychuk U
RNA Biol. 2024; 21(1):1-10.
PMID: 39183472
PMC: 11352719.
DOI: 10.1080/15476286.2024.2388911.
Smart A, Gilmer O, Caliskan N
Viruses. 2024; 16(7).
PMID: 39066259
PMC: 11281336.
DOI: 10.3390/v16071097.
Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families.
de Andrade K, Cesar Cirne-Santos C
Pathogens. 2023; 12(12).
PMID: 38133344
PMC: 10747524.
DOI: 10.3390/pathogens12121461.
SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks".
Sievers B, Cheng M, Csiba K, Meng B, Gupta R
Cell Mol Immunol. 2023; 21(2):171-183.
PMID: 37985854
PMC: 10805730.
DOI: 10.1038/s41423-023-01104-y.
PARP-nucleic acid interactions: Allosteric signaling, PARP inhibitor types, DNA bridges, and viral RNA surveillance.
Pascal J
Curr Opin Struct Biol. 2023; 81:102643.
PMID: 37352603
PMC: 10801860.
DOI: 10.1016/j.sbi.2023.102643.
Role of Dynamics and Mutations in Interactions of a Zinc Finger Antiviral Protein with CG-rich Viral RNA.
Pal S, Kumar A, Vashisth H
J Chem Inf Model. 2023; 63(3):1002-1011.
PMID: 36707411
PMC: 10129844.
DOI: 10.1021/acs.jcim.2c01487.
Crystal structures and functional analysis of the ZnF5-WWE1-WWE2 region of PARP13/ZAP define a distinctive mode of engaging poly(ADP-ribose).
Kuttiyatveetil J, Soufari H, Dasovich M, Uribe I, Mirhasan M, Cheng S
Cell Rep. 2022; 41(4):111529.
PMID: 36288691
PMC: 9720839.
DOI: 10.1016/j.celrep.2022.111529.
Riplet Binds the Zinc Finger Antiviral Protein (ZAP) and Augments ZAP-Mediated Restriction of HIV-1.
Buckmaster M, Goff S
J Virol. 2022; 96(16):e0052622.
PMID: 35913217
PMC: 9400502.
DOI: 10.1128/jvi.00526-22.
Host and Viral Zinc-Finger Proteins in COVID-19.
Esposito S, DAbrosca G, Antolak A, Pedone P, Isernia C, Malgieri G
Int J Mol Sci. 2022; 23(7).
PMID: 35409070
PMC: 8998646.
DOI: 10.3390/ijms23073711.
Host ADP-ribosylation and the SARS-CoV-2 macrodomain.
Hoch N
Biochem Soc Trans. 2021; 49(4):1711-1721.
PMID: 34351418
PMC: 8421052.
DOI: 10.1042/BST20201212.
RNA Helicase DDX17 Inhibits Hepatitis B Virus Replication by Blocking Viral Pregenomic RNA Encapsidation.
Mao R, Dong M, Shen Z, Zhang H, Liu Y, Cai D
J Virol. 2021; 95(19):e0044421.
PMID: 34287051
PMC: 8428406.
DOI: 10.1128/JVI.00444-21.
SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response.
Franzo G
Sci Rep. 2021; 11(1):10696.
PMID: 34021237
PMC: 8139983.
DOI: 10.1038/s41598-021-90278-4.
The Zinc Finger Antiviral Protein ZAP Restricts Human Cytomegalovirus and Selectively Binds and Destabilizes Viral / Transcripts.
Gonzalez-Perez A, Stempel M, Wyler E, Urban C, Piras A, Hennig T
mBio. 2021; 12(3).
PMID: 33947766
PMC: 8263000.
DOI: 10.1128/mBio.02683-20.
Viral Respiratory Pathogens and Lung Injury.
Clementi N, Ghosh S, De Santis M, Castelli M, Criscuolo E, Zanoni I
Clin Microbiol Rev. 2021; 34(3).
PMID: 33789928
PMC: 8142519.
DOI: 10.1128/CMR.00103-20.
Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.
Gupta V, Haider S, Verma M, Singhvi N, Ponnusamy K, Malik M
mSystems. 2021; 6(1).
PMID: 33622851
PMC: 8573956.
DOI: 10.1128/mSystems.00030-21.
Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections.
Acosta P, Byrne A, Hijano D, Talarico L
J Immunol Res. 2020; 2020:1372494.
PMID: 32455136
PMC: 7231083.
DOI: 10.1155/2020/1372494.
Role of Divalent Cations in HIV-1 Replication and Pathogenicity.
Khan N, Chen X, Geiger J
Viruses. 2020; 12(4).
PMID: 32326317
PMC: 7232465.
DOI: 10.3390/v12040471.
